Marie Lindquist
Marie Lindquist
Director, Uppsala Monitoring Centre
Geverifieerd e-mailadres voor who-umc.org - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
What is pharmacoepidemiology?
BL Strom
Pharmacoepidemiology, 1-26, 2019
12382019
A Bayesian neural network method for adverse drug reaction signal generation
A Bate, M Lindquist, IR Edwards, S Olsson, R Orre, A Lansner, ...
European journal of clinical pharmacology 54 (4), 315-321, 1998
9111998
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek, A Bate, HGM Leufkens, M Lindquist, R Orre, ...
Pharmacoepidemiology and drug safety 11 (1), 3-10, 2002
7302002
VigiBase, the WHO global ICSR database system: basic facts
M Lindquist
Drug Information Journal 42 (5), 409-419, 2008
3872008
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
DM Coulter, A Bate, RHB Meyboom, M Lindquist, IR Edwards
Bmj 322 (7296), 1207-1209, 2001
3412001
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database
M Lindquist, M Sthl, A Bate, IR Edwards, RHB Meyboom
Drug safety 23 (6), 533-542, 2000
2162000
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database
M Lindquist, M Sthl, A Bate, IR Edwards, RHB Meyboom
Drug safety 23 (6), 533-542, 2000
2162000
An ABC of drug-related problems
RHB Meyboom, M Lindquist, ACG Egberts
Drug safety 22 (6), 415-423, 2000
1862000
Quality criteria for early signals of possible adverse drug reactions
IR Edwards, M Lindquist, BE Wiholm, E Napke
The Lancet 336 (8708), 156-158, 1990
1701990
Risks of non-sedating antihistamines
M Lindquist, IR Edwards
The Lancet 349 (9061), 1322, 1997
1691997
A data mining approach for signal detection and analysis
A Bate, M Lindquist, IR Edwards, R Orre
Drug safety 25 (6), 393-397, 2002
1612002
International monitoring of adverse health effects associated with herbal medicines
MH Farah, R Edwards, M Lindquist, C Leon, D Shaw
Pharmacoepidemiology and Drug Safety 9 (2), 105-112, 2000
1372000
Signal selection and follow-up in pharmacovigilance
RHB Meyboom, M Lindquist, ACG Egberts, IR Edwards
Drug safety 25 (6), 459-465, 2002
1322002
Bayesian neural networks with confidence estimations applied to data mining
R Orre, A Lansner, A Bate, M Lindquist
Computational Statistics & Data Analysis 34 (4), 473-493, 2000
1282000
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system
MMS Stahl, M Lindquist, M Pettersson, IR Edwards, JH Sanderson, ...
European journal of clinical pharmacology 53 (3), 163-169, 1997
1211997
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
HJ Derijks, RHB Meyboom, ER Heerdink, FHP De Koning, R Janknegt, ...
European journal of clinical pharmacology 64 (5), 531-538, 2008
1202008
From association to alert—a revised approach to international signal analysis
M Lindquist, IR Edwards, A Bate, H Fucik, AM Nunes, M Sthl
Pharmacoepidemiology and drug safety 8 (S1), S15-S25, 1999
1121999
vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues
T Bergvall, GN Norn, M Lindquist
Drug safety 37 (1), 65-77, 2014
1052014
The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO database
A Bate, M Lindquist, IR Edwards
Fundamental & clinical pharmacology 22 (2), 127-140, 2008
832008
Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs
A Bate, M Lindquist, R Orre, I Edwards, R Meyboom
European journal of clinical pharmacology 58 (7), 483-490, 2002
792002
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20